Search

Background and Objectives: Hyperuricemia is associated with a variety of comorbidities. The objective of this study was to investigate the association between hyperuricemia and hearing impairment in Korean adults. Materials and Methods: Audiometric and laboratory test data from the 2019 to 2020 Korean National Health and Nutrition Examination Survey (KNHANES) were used for analysis. Hearing impairment was defined as a pure-tone average (0.5, 1, 2, 4 kHz) threshold level ≥ 41 decibels. The definition of hyperuricemia was different for males and females: >7 mg/dL for males vs. >6 mg/dL for females. Results: A total of 4857 (weight n = 17,990,725) subjects were analyzed. The mean age was 56.8 years old. The weighted prevalence was 12.1% for hyperuricemia and 2.5% for gout. The prevalence of hearing impairment was 13.4%. In the univariable analysis, hyperuricemia was significantly associated with hearing impairment. However, the diagnosis of gout was not associated with hearing impairment. In the multivariable analysis, hyperuricemia (odds ratios (OR): 1.41, 95% confidence interval [CI]: 1.03–1.92, p = 0.030) was associated with hearing impairment along with age (OR: 1.12, 95% CI: 1.10–1.14, p < 0.001), female sex (OR: 0.43, 95% CI: 0.34–0.64, p < 0.001), education (OR: 0.43, 95% CI: 0.30–0.63, p = 0.001), and occupational noise exposure (OR: 1.67, 95% CI: 1.25–2.22, p = 0.001). In the subgroup analysis, hyperuricemia was associated with hearing impairment in females (OR: 1.59, 95% CI: 1.02–2.48, p = 0.041) and the elderly aged 60 years or more (OR: 1.45, 95% CI: 1.05–1.99, p = 0.023). Conclusions: Hyperuricemia was independently associated with hearing impairment, especially in females and the elderly aged 60 years or more. [ABSTRACT FROM AUTHOR]

The soil vulnerability index (SVI) classifies vulnerability to cropland pollutant transport by surface runoff and leaching, helping to categorize areas with a high contribution of pollutant loads. This study aims to 1) adopt the SVI classification scheme in South Korea and 2) suggest a modified SVI classification scheme for surface runoff to anticipate climate change impacts. The precipitation amount was considered in an original scheme to make a modified scheme. The results with an original SVI classification scheme predicted that the SVI surface runoff vulnerability was relatively greater in areas with a steep slope than in those with a plain topography, and a high level of the SVI leaching vulnerability was frequently observed in plain areas. When a modified SVI classification scheme was applied, "High" vulnerability class increased from 44.0% to 57.4% and the greater increase rate was observed in the regions susceptible to heavy precipitation defined as a day with more than 80 mm precipitation. When compared with observational suspended solids, the results with a modified SVI classification scheme were more consistent with observations than those with an original SVI classification scheme. Relative to the baseline period, the SVI surface runoff vulnerability of "High" class increased by 47.1–88.7% during the climate change period. When the number of vulnerability classes was increased, the differences on "Very extremely high" class between the baseline and projection periods were clear with the increase rate of 16.4–343%. The results with an original SVI classification scheme matched well with the topographic characteristics, and a modified SVI classification scheme captured the impacts of regional precipitation patterns and climate change impacts. As a first approach to adopting the SVI classification system to South Korea, increasing the number of classifications in regions with excessive rainfall amounts can improve identifying those most vulnerable areas. • The SVI was developed to classify soil vulnerability classes to cropland pollutant. • The SVI classification scheme was tested on croplands across South Korea. • The SVI classification results agreed well with topographic characteristics. • An original classification scheme was modified to consider precipitation amount. • A modified classification scheme showed enhanced SVI classification results. [ABSTRACT FROM AUTHOR]

Purpose: To investigate urine microbiome differences among healthy women, women with recurrent uncomplicated cystitis (rUC), and those with sporadic/single uncomplicated cystitis (sUC) to challenge traditional beliefs about origins of these infections., Materials and Methods: Patients who underwent both conventional urine culture and next-generation sequencing (NGS) of urine were retrospectively reviewed. Symptom-free women with normal urinalysis results as a control group were also studied. Samples were collected via transurethral catheterization., Results: In the control group, urine microbiome was detected on NGS in 83.3%, with Lactobacillus and Prevotella being the most abundant genera. The sensitivity of urine NGS was significantly higher than that of conventional urine culture in both the sUC group (91.2% vs. 32.4%) and the rUC group (82.4% vs. 16.4%). In urine NGS results, Enterobacterales , Prevotella , and Escherichia / Shigella were additionally found in the sUC group, while the recurrent urinary tract infection (rUTI)/rUC group exhibited the presence of Lactobacillus , Prevotella , Enterobacterales , Escherichia / Shigella , and Propionibacterium . Moreover, distinct patterns of urine NGS were observed based on menopausal status and ingestion of antibiotics or probiotics prior to NGS test sampling., Conclusions: Urine microbiomes in control, sUC, and rUTI/rUC groups exhibited distinct characteristics. Notably, sUC and rUC might represent entirely separate pathological processes, given their distinct urine microbiomes. Consequently, the use of urine NGS might be essential to enhancing sensitivity compared to conventional urine culture in both sUC and rUTI/rUC groups., Competing Interests: The authors have nothing to disclose., (© The Korean Urological Association.)

Prognosis has not been known for patients with fever of unknown origin (FUO) whose ¹⁸fluoro-deoxyglucose (¹⁸F-FDG) positron emission tomography/computerized tomography (PET/CT) finding is non-diagnostic. A total of eight patients with FUO that underwent ¹⁸F-FDG PET/CT were retrospectively identified January 2016 - June 2017 in a tertiary hospital in Korea. Of these, two patients were diagnosed with microscopic polyangitis and Kikuchi's disease and one patient was transferred to another hospital. Of five patients whose diagnoses were not confirmed, four patients received non-steroidal anti-inflammatory drug and/or low dose steroid and symptoms disappeared. Our study suggests that outcome of patients with FUO whose ¹⁸F-FDG PET/CT finding is non-diagnostic would be favorable., Competing Interests: No conflicts of interest., (Copyright © 2018 by The Korean Society of Infectious Diseases and Korean Society for Chemotherapy.)

Objective: The development of anti-drug antibodies (ADAbs) against tumor necrosis factor (TNF) inhibitors is a likely explanation for the failure of TNF-inhibitors in patients with spondyloarthritis (SpA). Our study determined the existence and clinical implications of ADAbs in axial SpA patients., Methods: According to the Assessment of SpondyloArthritis International Society classification criteria for axial SpA, patients treated with adalimumab or infliximab were recruited consecutively. Serum samples were collected at enrollment to measure ADAb and drug levels., Results: Of 100 patients, the mean duration of current TNF inhibitor use was 22.3±17.9 months. ADAbs were detected in 5 of 72 adalimumab users compared to 5 of 28 infliximab users (6.9% vs. 17.9%). ADAb-positive patients had a significantly higher body mass index than ADAb-negative patients among both adalimumab (28.4±5.9kg/m 2 vs. 24.3±2.9kg/m 2 , respectively, p=0.01) and infliximab users (25.9±2.8kg/m 2 vs. 22.6±2.8kg/m 2 , respectively, p=0.02). During the median 15-month follow-up period, drug discontinuation occurred more frequently in the ADAb-positive group than the ADAb-negative group (30.0% vs. 6.5%, respectively, p=0.04). In logistic regression, ADAb positivity (OR=5.85, 95% CI 1.19-28.61, p=0.029) and BMI (OR=4.35, 95% CI 1.01-18.69, p=0.048) were associated with a greater risk of stopping TNF inhibitor treatment., Conclusions: Our result suggests that the presence of ADAbs against adalimumab and infliximab as well as a higher BMI can predict subsequent drug discontinuation in axial SpA patients., (Copyright © 2016. Published by Elsevier Editora Ltda.)